Introduction
Rationale 3 Describe the rationale for the review in the context of what is already known. Pgs. 5 -6
Objectives 4
Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
Pg. 6

Methods
Protocol and registration 5
Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.
Pg. S2
Eligibility criteria 6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.
Pgs. 6 -7
Information sources 7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.
Pgs. 6 -7 and S2 Search 8 Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.
Study selection 9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).
Pg. 7 and S2
Data collection process 10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
Pgs. 6 -7 and S2
Data items 11
List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.
Pg. S2
Risk of bias in individual studies 12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.
Summary measures 13 State the principal summary measures (e.g., risk ratio, difference in means). Pg. 8
Synthesis of results 14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I
2 ) for each meta-analysis.
Pgs. 8 -9 and S2
Risk of bias across studies 15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).
Pgs. 8 -9
Additional analyses 16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.
Pgs. 7 -9
Results
Study selection 17
Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
Pg. 11; Fig S1
Study characteristics 18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.
Pgs. 11; Tabs S1 -S2 
Data Inputs
For all data inputs from multiple sources that are synthesized as part of the study: 3 Describe how the data were identified and how the data were accessed. Pg. S3 4
Specify the inclusion and exclusion criteria. Identify all ad-hoc exclusions. Not applicable, as relevant data sources were identified based on expert opinion rather than literature searches 5
Provide information on all included data sources and their main characteristics. For each data source used, report reference information or contact name/institution, population represented, data collection method, year(s) of data collection, sex and age range, diagnostic criteria or measurement method, and sample size, as relevant.
Pgs. 10 -11 and S3 6 Identify and describe any categories of input data that have potentially important biases (e.g., based on characteristics listed in item 5).
Pg. S3 For data inputs that contribute to the analysis but were not synthesized as part of the study:
7 Describe and give sources for any other data inputs.
Pgs. 10 -11 For all data inputs:
8 Provide all data inputs in a file format from which data can be efficiently extracted (e.g., a spreadsheet rather than a PDF), including all relevant meta-data listed in item 5. For any data inputs that cannot be shared because of ethical or legal reasons, such as third-party ownership, provide a contact name or the name of the institution that retains the right to the data.
All relevant data sources are publically available from the references cited. They are not presented as the World Health Organization retains the rights to these data.
Data analysis 9 Provide a conceptual overview of the data analysis method. A diagram may be helpful. Pgs. 10 -11 10 Provide a detailed description of all steps of the analysis, including mathematical formulae. This description should cover, as relevant, data cleaning, data pre-processing, data adjustments and weighting of data sources, and mathematical or statistical model(s).
Pgs. 10 -11 and S3
11
Describe how candidate models were evaluated and how the final model(s) were selected. Pgs. 10 -11 12
Provide the results of an evaluation of model performance, if done, as well as the results of any relevant sensitivity analysis. Pgs. 10 -11 13
Describe methods for calculating uncertainty of the estimates. State which sources of uncertainty were, and were not, accounted for in the uncertainty analysis.
Pgs. 10 -11 and S3 
